Australian Clinical Labs Ltd (AU:ACL) — Stock Price

AU$2.36 AUD
▼ -0.84% today

Australian Clinical Labs Ltd (AU:ACL) is currently trading at AU$2.36 AUD, down 0.84% today. Over the past 52 weeks, shares have ranged between AU$1.84 and AU$2.92. This page tracks Australian Clinical Labs Ltd's live share price on the AU exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see market value of Australian Clinical Labs Ltd.

Australian Clinical Labs Ltd (ACL) Stock Price Chart — Daily History & Trading Volume

The chart below tracks Australian Clinical Labs Ltd's daily closing share price and trading volume on the AU exchange over the past year, giving a clear view of recent price momentum and liquidity.

Australian Clinical Labs Ltd Income Statement — Revenue, Profit & Earnings by Year

Australian Clinical Labs Ltd's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.

Fiscal Year 20252024202420232023
Total Revenue AU$741.27 Million AU$741.27 Million AU$689.73 Million AU$689.73 Million AU$692.10 Million
Cost of Revenue AU$470.41 Million AU$470.41 Million AU$551.28 Million AU$551.28 Million AU$126.08 Million
Gross Profit AU$270.86 Million AU$270.86 Million AU$138.45 Million AU$138.45 Million AU$566.02 Million
Research & Development — — — — —
SG&A AU$329.06 Million AU$329.06 Million AU$312.67 Million AU$312.67 Million AU$297.39 Million
Total Operating Expenses AU$89.98 Million AU$89.98 Million AU$81.55 Million AU$81.55 Million AU$514.05 Million
Operating Income AU$270.86 Million AU$270.86 Million AU$56.91 Million AU$56.91 Million AU$56.07 Million
EBITDA AU$81.36 Million AU$81.36 Million AU$169.65 Million AU$169.65 Million AU$184.93 Million
EBIT AU$68.00 Million AU$68.00 Million AU$41.22 Million AU$41.22 Million AU$62.17 Million
Interest Expense AU$18.37 Million AU$18.37 Million AU$17.04 Million AU$17.04 Million AU$13.87 Million
Income Before Tax AU$48.18 Million AU$48.18 Million AU$36.37 Million AU$36.37 Million AU$48.31 Million
Income Tax Expense AU$15.36 Million AU$15.36 Million AU$12.12 Million AU$12.12 Million AU$12.27 Million
Net Income AU$32.43 Million AU$32.43 Million AU$23.93 Million AU$23.93 Million AU$35.90 Million

Australian Clinical Labs Ltd Balance Sheet — Assets, Liabilities & Shareholder Equity

The balance sheet below summarizes Australian Clinical Labs Ltd's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.

Fiscal Year 20252024202420232023
Total Assets AU$574.84 Million AU$574.84 Million AU$593.06 Million AU$593.06 Million AU$578.91 Million
Total Current Assets AU$120.06 Million AU$120.06 Million AU$133.60 Million AU$133.60 Million AU$115.96 Million
Cash & Equivalents AU$21.44 Million AU$21.44 Million AU$26.14 Million AU$26.14 Million AU$19.95 Million
Short-term Investments AU$679.00K AU$679.00K AU$709.00K AU$709.00K AU$632.00K
Net Receivables AU$70.33 Million AU$70.33 Million AU$81.43 Million AU$81.43 Million AU$74.96 Million
Inventory AU$15.62 Million AU$15.62 Million AU$16.83 Million AU$16.83 Million AU$15.09 Million
Property, Plant & Equipment AU$270.11 Million AU$270.11 Million AU$281.70 Million AU$281.70 Million AU$288.44 Million
Goodwill AU$159.11 Million AU$159.11 Million AU$158.68 Million AU$158.68 Million AU$158.68 Million
Total Liabilities AU$402.86 Million AU$402.86 Million AU$415.30 Million AU$415.30 Million AU$406.24 Million
Total Current Liabilities AU$216.41 Million AU$216.41 Million AU$207.70 Million AU$207.70 Million AU$187.93 Million
Long-term Debt AU$41.97 Million AU$41.97 Million AU$55.06 Million AU$55.06 Million AU$65.70 Million
Net Debt AU$268.94 Million AU$268.94 Million AU$282.76 Million AU$282.76 Million AU$296.36 Million
Total Stockholder Equity AU$171.35 Million AU$171.35 Million AU$177.53 Million AU$177.53 Million AU$172.42 Million
Retained Earnings AU$33.75 Million AU$33.75 Million AU$159.05 Million AU$159.05 Million AU$155.24 Million

Australian Clinical Labs Ltd Cash Flow Statement — Operating, Investing & Financing Activities

This cash flow statement breaks down how Australian Clinical Labs Ltd generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.

Fiscal Year 20252024202420232023
Operating Cash Flow AU$182.80 Million AU$182.80 Million AU$159.59 Million AU$159.59 Million AU$143.68 Million
Capital Expenditures AU$8.41 Million AU$8.41 Million AU$6.50 Million AU$6.50 Million AU$6.93 Million
Free Cash Flow AU$174.39 Million AU$174.39 Million AU$153.09 Million AU$153.09 Million AU$136.75 Million
Investing Cash Flow AU$-8.89 Million AU$-8.89 Million AU$-7.25 Million AU$-7.25 Million AU$-12.18 Million
Financing Cash Flow AU$-178.74 Million AU$-178.74 Million AU$-146.14 Million AU$-146.14 Million AU$-137.88 Million
Dividends Paid AU$24.95 Million AU$-24.95 Million AU$19.95 Million AU$-19.95 Million AU$96.88 Million
Stock-Based Compensation AU$3.44 Million AU$3.44 Million AU$3.06 Million AU$3.06 Million AU$1.88 Million
Depreciation AU$136.04 Million AU$136.04 Million AU$128.43 Million AU$128.43 Million AU$122.75 Million
Change in Cash AU$-4.69 Million AU$-4.69 Million AU$6.18 Million AU$6.18 Million AU$-6.42 Million

Australian Clinical Labs Ltd Earnings History — EPS Actual vs. Analyst Estimates

Track Australian Clinical Labs Ltd's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.

Report Date EPS Actual EPS Estimate Surprise
Feb 23, 2026 — — —
Aug 26, 2025 0.12 — —
Feb 25, 2025 0.06 0.00 —
Feb 19, 2023 0.13 0.00 —
Nov 30, 2022 0.00 0.00 —
Aug 09, 2022 0.24 0.00 —
Feb 23, 2022 0.65 0.00 —
Aug 26, 2021 0.02 0.00 —